Spots Global Cancer Trial Database for stage iv bladder urothelial carcinoma ajcc v7
Every month we try and update this database with for stage iv bladder urothelial carcinoma ajcc v7 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder for Bladder Cancer Treatment, MODERN Study | NCT05987241 | Muscle Invasive... Stage II Bladde... Stage III Bladd... Stage IV Bladde... | Biospecimen Col... cfDNA or ctDNA ... Computed Tomogr... Magnetic Resona... Nivolumab Quality-of-Life... Questionnaire A... Relatlimab | 18 Years - | National Cancer Institute (NCI) | |
| Gemcitabine Hydrochloride and Eribulin Mesylate in Treating Patients With Bladder Cancer That is Advanced or Cannot Be Removed by Surgery | NCT02178241 | Metastatic Uret... Metastatic Uret... Stage III Bladd... Stage III Urete... Stage III Ureth... Stage IV Bladde... Stage IV Ureter... Stage IV Urethr... Ureter Urotheli... Urethral Urothe... | Eribulin Mesyla... Gemcitabine Hyd... | 18 Years - | National Cancer Institute (NCI) | |
| Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer | NCT01050504 | Localized Renal... Malignant Solid... Metastatic Mali... Metastatic Mali... Metastatic Rena... Recurrent Bladd... Recurrent Prost... Recurrent Renal... Stage IV Bladde... Stage IV Bladde... Stage IV Prosta... | Cytology Specim... Laboratory Biom... | 18 Years - | University of Washington | |
| Sapanisertib in Treating Patients With Locally Advanced or Metastatic Bladder Cancer With TSC1 and/or TSC2 Mutations | NCT03047213 | Locally Advance... Metastatic Tran... Metastatic Urot... Recurrent Bladd... Stage III Bladd... Stage IV Bladde... | Sapanisertib | 18 Years - | National Cancer Institute (NCI) | |
| Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction | NCT00365157 | Advanced Urothe... Locally Advance... Metastatic Urot... Recurrent Uroth... Stage III Bladd... Stage IV Bladde... Unresectable Ur... | Eribulin Mesyla... Laboratory Biom... Pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Cisplatin and Gemcitabine Hydrochloride With or Without Berzosertib in Treating Patients With Metastatic Urothelial Cancer | NCT02567409 | Metastatic Blad... Metastatic Rena... Metastatic Uret... Stage IV Bladde... | Berzosertib Cisplatin Gemcitabine Hyd... | 18 Years - | National Cancer Institute (NCI) | |
| Gemcitabine Hydrochloride and Eribulin Mesylate in Treating Patients With Bladder Cancer That is Advanced or Cannot Be Removed by Surgery | NCT02178241 | Metastatic Uret... Metastatic Uret... Stage III Bladd... Stage III Urete... Stage III Ureth... Stage IV Bladde... Stage IV Ureter... Stage IV Urethr... Ureter Urotheli... Urethral Urothe... | Eribulin Mesyla... Gemcitabine Hyd... | 18 Years - | National Cancer Institute (NCI) | |
| Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer | NCT01050504 | Localized Renal... Malignant Solid... Metastatic Mali... Metastatic Mali... Metastatic Rena... Recurrent Bladd... Recurrent Prost... Recurrent Renal... Stage IV Bladde... Stage IV Bladde... Stage IV Prosta... | Cytology Specim... Laboratory Biom... | 18 Years - | University of Washington | |
| Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer | NCT01050504 | Localized Renal... Malignant Solid... Metastatic Mali... Metastatic Mali... Metastatic Rena... Recurrent Bladd... Recurrent Prost... Recurrent Renal... Stage IV Bladde... Stage IV Bladde... Stage IV Prosta... | Cytology Specim... Laboratory Biom... | 18 Years - | University of Washington | |
| Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer | NCT00942331 | Advanced Urothe... Metastatic Blad... Metastatic Pros... Metastatic Rena... Metastatic Uret... Metastatic Uret... Metastatic Urot... Stage IV Bladde... Stage IV Prosta... Stage IV Renal ... Stage IV Ureter... Stage IV Urethr... Unresectable Ur... | Bevacizumab Cisplatin Gemcitabine Hyd... Laboratory Biom... Placebo Adminis... | 18 Years - | National Cancer Institute (NCI) | |
| Sapanisertib in Treating Patients With Locally Advanced or Metastatic Bladder Cancer With TSC1 and/or TSC2 Mutations | NCT03047213 | Locally Advance... Metastatic Tran... Metastatic Urot... Recurrent Bladd... Stage III Bladd... Stage IV Bladde... | Sapanisertib | 18 Years - | National Cancer Institute (NCI) | |
| Nivolumab and RT in Treating Patients With Localized/Locally Advanced Urothelial Bladder Cancer Ineligible for Chemo | NCT03421652 | Stage II Bladde... Stage III Bladd... Stage IV Bladde... | Nivolumab Radiation | 18 Years - | Barbara Ann Karmanos Cancer Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
